J8we've all learnt to know how pessimistic you are with all...

J8

we've all learnt to know how pessimistic you are with all things Biotron, but your take on it today is worn out at best, and quite misleading at worse.

If you think this is the same as before, then you have your head in the sand. But you're too smart to think that........ however, attitudes do get in the way of clear thinking.

The trials intentions have been realized. Confirmation of previous trial data has been met, and extension....... The extension is to do with the reserviour cells because that was the unknown efficacy prior, so you have no grounds (at this stage) to state, it still only works in the macros and not all of the hidden reservoirs.

Rather, the trial clearly demonstrates the increased rate (rapid) of reduced HIV in blood plasma, and this is when reserviour accumulation occurs, as MM indicates in her comments. Successfully reducing viral loads in blood beyond CART is more than has occurred in 40 years of HIV treatment, and the effect on reserviours, even though not numerically yet shown, is one of the two aspects that make 225 different. The other is in the significant effect on immunity.

All in all, BIT2225 is sizing itself up to become a game changer for HIV treatmnet.

As much as this is all great news for treating HIV, my first love is treating C19, besides J8 of course.

Not long now.